grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

July 19, 2018

NYU Langone Health Expands Strategic Partnership with Omnicell for Automated Medication Management Solutions

Download PDF
Collaboratively Developed Technologies Support Patient-Centric Care By Allowing Nurses to Spend More Time at the Bedside

MOUNTAIN VIEW, Calif., July 19, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that NYU Langone Health in New York has chosen the Company's automated medication management platform to help improve patient outcomes at its new inpatient hospital, the Helen L. and Martin S. Kimmel Pavilion. The addition of Omnicell® XT Automated Medication Dispensing Cabinets, Omnicell XT Anesthesia Workstation™, and Omnicell XT Controlled Substance Manager in the state-of-the-art facility builds on the health system's long-time relationship with Omnicell. NYU Langone is ranked in the top 20 Best Hospital Honor Roll by U.S. News and World Report.1

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

In a recent survey 87 percent of registered nurses agreed that they are playing an increasingly important role in patient management and care coordination.2 In order to help improve nursing workflow efficiency and elevate nurses' roles in patient-facing interactions, NYU Langone collaborated with Omnicell to develop an innovative medication management strategy that places medications in secure storage drawers and is integrated into the Omnicell software platform and the hospital's electronic health record. Helping support the needs of patients and staff, the patient-specific medication storage device is located near the patient bedside and is intended to further enhance efficiency and allow nurses to spend more time with each patient.

Complementing this technology, NYU Langone selected Omnicell XT cabinets, which incorporate the latest hardware technology and smart software features to help improve medication safety. These cabinets are integrated with the XT Controlled Substance Manager, which provides perpetual inventory management and an automated audit trail for controlled substances to help the pharmacy comply with regulatory standards while increasing efficiency.

"The ability to create a new building from the ground up has allowed us to incorporate the most advanced automation infrastructure to support excellent care," said Mark Pollard, vice president of operations at NYU Langone. "Through our partnership with Omnicell, we were able to create a technology strategy with customized solutions that best fit our patient-focused goals, ultimately creating a facility that puts patients at the center of care."

To help maintain safety in the operating suites, the health system chose the XT Anesthesia Workstation, which securely stores medications and supplies needed for a full day of cases. The automated system also tracks inventory used and gives anesthesia providers instant access to medications while cutting hours of manual documentation for the pharmacy.

"Over the years, we have continued to be impressed by NYU Langone's dedication to delivering the highest level of care to their community. The new facility offers a rare opportunity to apply best practices they have developed for patient care to all areas of the hospital," said Scott Seidelmann, chief commercialization officer at Omnicell. "We are proud to support NYU Langone's commitment to innovation and vision for positive patient outcomes through our automated medication management solutions."

1US News and World Report, "2017-18 Best Hospitals Honor Roll and Overview" (August 2018).
2Health IT Analytics, "Over 80% of Nurses See Increased Role in Patient Management" (May 2018).

About NYU Langone Health

NYU Langone Health is a world-class, patient-centered, integrated academic medical center, known for its excellence in clinical care, research, and education. It comprises more than 200 locations throughout the New York area, including five inpatient locations, a children's hospital, three emergency rooms and a level 1 trauma center. Also part of NYU Langone Health is the Laura and Isaac Perlmutter Cancer Center, a National Cancer Institute–designated cancer center, and NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. For more information, go to, and interact with us on FacebookTwitterYouTube, and Instagram.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,500 facilities worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.


Cision View original content with multimedia:

SOURCE Omnicell, Inc.

Betsy Martinelli; Omnicell, Inc.; (724) 741-8341; OR Jessika Parry; Next Step Communications; (781) 326-1741;